MedTrace Logo

Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions

NCT05330507 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-11-03

No results posted yet for this study

Summary

This prospective, observational study is designed to investigate clinical outcomes and collect patient feedback on the use of Wellinks, an integrated virtual chronic obstructive pulmonary disease (COPD) management solution, for patients recently discharged from the hospital due to an acute exacerbation of their COPD.

Conditions

  • COPD
  • Respiratory Tract Disease
  • Pulmonary Disease, Chronic Obstructive
  • Lung Diseases, Obstructive
  • Lung Diseases

Interventions

OTHER

Wellinks

30-day post-discharge period: virtual respiratory therapist sessions twice per week with synchronous virtual pulmonary rehabilitation and educational materials; at-home use of connected spirometer and pulse oximeter; at-home use of mobile app. 12-week intensive period: virtual health coaching sessions once every two weeks; asynchronous virtual pulmonary rehabilitation program; ongoing access to connected devices (spirometer and pulse oximeter) and mobile app.

Sponsors & Collaborators

  • Hartford HealthCare

    collaborator OTHER

  • Convexity Scientific Inc

    lead INDUSTRY

Principal Investigators

  • Syed Hadi, MD · Hartford HealthCare

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-05
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05330507 on ClinicalTrials.gov